Category: Anthony Fauci

How Doctors and Hospitals Can Help Defeat COVID-19 Vaccine Resistance and Misinformation

Anthony Fauci, coronavirus, coronavirus mutations, COVID-19, Covid-19 vaccines, Healthcare Editorial, Healthcare Marketing Leadership, healthcare reform, Rochelle Walensky, Vaccine Patient Education, Vaccine Resistance, We Can Do This / April 8, 2021 April 8, 2021

There’s a recent rise in national optimism that says—maybe—we have turned the corner on the pandemic lockdown. Admittedly, it’s been a tough year for nearly everyone, but miraculous vaccines and declining death rates have stirred newfound optimism. COVID-19 PUBLIC EDUCATION CAMPAIGN by the U.S. Department of Health and Human Services. But wait — unfortunately, the …

How Doctors and Hospitals Can Help Defeat COVID-19 Vaccine Resistance and Misinformation Read More »

Dr Fauci: We won’t be able to crush Covid-19 like smallpox without strong global vaccination

Anthony Fauci, BioPharma, Covid-19 vaccines, Daily, News, Physicians, Policy, Precision Medicine World Congress, SYN, Top Story / January 25, 2021 January 25, 2021

Dr. Fauci stressed that whether humanity can root out the novel coronavirus depends on whether a robust global vaccine campaign can be launched such that cheaper and easily deliverable vaccines can be distributed en masse.

2020: The Phenomena and personalities in the year that was

AI chatbots, Anthony Fauci, Artificial Intelligence, BioPharma, Community, Daily, Diagnostics, Donald Trump, hospitals, Legal, News, Top Story / December 20, 2020 December 20, 2020

Here is our attempt to capture this bewildering and memorable year by highlighting the phenomena and personalities who made it so.

Take it from an expert: Fauci’s hierarchy of safety during Covid

Anthony Fauci, Community, coronavirus, COVID-19, Kaiser, Policy, SYN, Top Story / November 23, 2020 November 23, 2020

A health journalist, a physician and a former foreign correspondent sits down with Dr. Anthony Fauci for a lengthy Q&A about safety during Covid times.

Report: FDA halted move to authorize convalescent plasma for Covid-19 over evidence concerns

Anthony Fauci, BioPharma, biopharma nl, convalescent plasma, coronavirus, COVID-19, Daily, FDA, Food and Drug Administration, Francis Collins, National Institute of Allergy and Infectious Diseases, National Institutes of Health, NIAID, NIH, Policy, SARS-CoV-2, SYN, Top Story / August 20, 2020 August 20, 2020

The New York Times reported that the FDA was prepared to issue an emergency use authorization for the treatment last week, but NIH Director Francis Collins and NIAID Director Anthony Fauci intervened, arguing that data were too weak.